Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/6/2025

Medroxyprogesterone Acetate Side Effects and Management

Introduction to Side Effects

  • Weight gain at 6 months is a strong predictor of future excessive weight gain with ongoing DMPA use 1
  • DMPA causes reductions in bone mineral density (BMD) 1
  • The FDA has issued a black-box warning about the risk of decreased BMD among DMPA users 1
  • Substantial recovery of BMD occurs after discontinuation of DMPA 1
  • Calcium intake (1300 mg daily) and vitamin D (600 IU daily) supplementation are recommended for all patients on DMPA 1

Cardiovascular and Bone Health Risks

  • Women using DMPA should be monitored for signs of thromboembolism 2
  • ACOG does not advise limiting DMPA use to 2 years, recognizing the risk of unwanted pregnancy if contraceptive options are limited 1

Special Considerations

  • When used in transgender care, progestins like medroxyprogesterone acetate can suppress testosterone levels via central feedback 3
  • Not recommended by the Endocrine Society for transgender care due to risk of breast cancer, thromboembolism, and stroke 3
  • Medroxyprogesterone acetate suppresses circulating androgen levels and pituitary gonadotropin levels in women with PCOS 4
  • Can be used to prevent endometrial cancer in women with PCOS, though optimal dosing and frequency are not established 4

Management of Side Effects

  • Counseling before initiation about expected menstrual changes improves continuation rates 1
  • Regular monitoring of weight and discussing lifestyle modifications may help manage weight gain 1
  • Consider alternative contraceptive methods if significant weight gain occurs within first 6 months 1
  • Regular weight-bearing exercise is recommended 1
  • Calcium (1300 mg daily) and vitamin D (600 IU daily) supplementation 1

Clinical Recommendations

  • Thorough pre-treatment counseling about potential side effects significantly improves continuation rates 1
  • Schedule follow-up visits every 11-12 weeks for adolescents (rather than every 13 weeks) to allow for missed or delayed visits 1
  • Failing to counsel patients about expected menstrual changes before initiating DMPA 1
  • Not monitoring weight changes, especially during the first 6 months of use 1
  • Overlooking the importance of calcium and vitamin D supplementation for bone health 1